Skip to content
Harbor Family Today

Zimbabwe Turns Down ‘One-Sided’ US Health Aid Deal Due to Data Apprehensions

Health funding image
The proposed American funding was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a major American health deal valued at 367 million US dollars (272 million pounds) over five years because of Washington's insistence on sensitive data.

This move became public following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa felt the deal was "lopsided".

A government representative has since clarified that the United States was requesting genetic material for scientific study and commercial purposes but was unwilling to guarantee the benefits from future vaccines.

"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has urged further talks to secure a deal acceptable to all parties so the nation's vital HIV treatment initiative can continue.

Broader Context

This rejection follows a similar situation in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were raised about the security of citizens' health data.

After resuming office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance openness and responsibility.

Based on statements, Sixteen African countries have so far signed similar agreements, constituting over $18.3bn of fresh investment.

Details of the Rejected Agreement

The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this cooperation could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"Our nation was requested to share its biological resources and data indefinitely, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.

"In essence, our country would provide the basic resources for medical research without any certainty that the end products would be accessible to our citizens if a new health crisis emerge."

National Interest and International Frameworks

Mangwana further said that the American exit from the global health body and its pursuit of one-on-one deals were undermining structures previously established via the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.

"This framework is intended to ensure that when a nation contributes its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.

"We welcome continued dialogue with our US partners on how subsequent collaboration might be arranged in a way that respects the independence and dignity of each country."

Health Experts Response

A leading public health body expressed it acknowledged the official position, but recommended that negotiations must proceed since a large portion of the country's HIV programmes were funded by foreign aid.

"If technical issues exist, such as those involving data governance or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," it commented.

The halted deal underscores the continuing tensions between accepting crucial foreign assistance and protecting a country's data in an increasingly data-driven world.

Written by

Jason Zavala

Elena is a seasoned journalist and mother of two, passionate about sharing family-friendly content that brings the harbor community together.

Harbor Family Today

Type to search articles.